Vasectomy Market 2018 –Major Vendors are Pfizer, Inc., Abbott, GlaxoSmithKline plc, Sanofi S.A., Novartis AG and more.

Vasectomy Market are rising demand due to growing population, increasing male-female equality, side effects of female contraception such as risk of cancer, hormonal disturbances, osteoporosis, rise in body weight etc., high safety profile of vasectomy and its simplicity over tubectomy, low cost of the surgical procedure and lack of hospitalization and others. The market restraints are the complications such as the risk of bleeding, infections, etc., lack of awareness, issues of male supremacy coupled with the non-reversible nature of vasectomy, social taboo, especially, in the developing regions and others.

Vasectomy market is expected to reach USD 24.0 billion at a CAGR of ~ 7.1 % during the by the end of forecast period 2017-2023. Some of the key players profiled in the report are Pfizer, Inc., Abbott, GlaxoSmithKline plc, Sanofi S.A., Novartis AG, Bayer AG, Bristol Myers Squibb Company, Eli Lilly and Company, Inc., Accurate Surgical & Scientific Instruments Corporation, Sklar Surgical Instruments, Advanced Meditech International and others.

Access Sample Copy @ https://www.marketresearchfuture.com/sample_request/4703 .

Market Synopsis of Global Vasectomy Market:

Vasectomy is permanent male sterilization surgery, which involves the male vas deferens being severed to prevent sperm from entering into the urethra and thus preventing fertilization. Vasectomy is performed by several methods such as open or conventional vasectomy, no-scalpel techniques or minimally invasive technique. Vasectomy is a permanent procedure as a reversal is costly and often does not restore the male's fertility due to low sperm count or sperm motility. Vasectomy is a simple surgical procedure, which takes less than thirty minutes and no hospital stay.  Most vasectomy patients can resume their sexual behavior within a week with little or no discomfort. Vasectomy may in some cases cause sperm granulomas due to the entry of the sperm into the scrotum and vasitis nodosa, which is a benign proliferation of the ductular epithelium. Vasectomy in about 60%-70% of cases causes anti-sperm antibodies.

Vasectomy is the most effective permanent contraception for men and has more positive outlook such as more cost-effective, less invasive, and has a much lower risk of postoperative complications. Almost 90% of men had reported satisfaction with vasectomy especially when both people in the relationship agreed on the procedure. Despite medical advances and the demonstration of the superiority of vasectomy, female sterilization is the most widely used method worldwide, with approx. 250 million tubectomy surgeries compared to a pitiful of approximately 30 million vasectomies.

Get Discount on Vasectomy Market Report @ https://www.marketresearchfuture.com/check-discount/4703 .

Segments:

The global vasectomy market has been classified into type, drugs, end user, and patients, On the basis of type, the market has been segmented as conventional vasectomy, no-scalpel vasectomy, and minimally invasive vasectomy. Based on the drugs, the market has been segmented as anesthetics, painkillers, antibiotics, and others. Based on the patients, the market has been segmented as human and animals. Based on the end user, the market has been segmented as hospitals and clinics, research and academics, and others.

Regional Analysis:

The Americas account for a major share of the market owing to high expenditure on the health care, especially, of the U.S. and Canada. Additionally, the greater number of vasectomies due to greater male-female equality in the U.S. and Canada drives the vasectomy market. The high concentration of the major hospitals in the developed countries of this region coupled with good reimbursement rates is adding fuel to the market growth. Moreover, the large share of surgeries in the returns of hospitals favors the market. Canada has a higher rate of people undergoing vasectomies than the U.S.

Europe is the second largest market in the world due to growing the pharmaceutical and industrial base. The European market growth is led by countries such as Germany and France. Germany is expected to be the fastest growing market over the assessment period. Belgium, Denmark, and Switzerland have a higher rate of people undergoing vasectomies than other nations of Europe.

Browse Complete Premium 110 Pages Half-Cooked Research Report Enabled with Respective Tables and Figures is Available @ https://www.marketresearchfuture.com/reports/vasectomy-market-4703

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

This release was published on openPR.